Last edition
News about Industrial talks
Shilpa Medicare arm collaborates with Dr Reddy's Labs for production of Sputnik V vaccine
Shilpa Medicare Limited via its wholly owned subsidiary Shilpa Biologicals Private Limited (SBPL), has entered into a 3 year definitive agreement with Dr Reddy's Laboratories Limited (DRL) for production-supply of the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka
Industrial talks | 18/05/2021 | By Darshana | 225
After the announcement by Indian Finance Minister, Nirmala Sitharaman to commit a 137% budget increase for healthcare and a nearly 200% boost for developing the pharma sector instills a high level of optimism in the industry.
Industrial talks | 04/02/2021 | By Hemant | 185
Roche and Regeneron announced today that they are joining forces in the fight against COVID-19 to develop, manufacture and distribute REGN-COV2, Regeneron's investigational antiviral antibody combination, to people around the globe.
Industrial talks | 21/08/2020 | By Darshana | 745
Medtronic to invest Rs. 1,200 crore to expand its R&D centre in Hyderabad
With Hyderabad fast emerging as Indias hub for medical devices manufacturing, the US-based Medtronic has decided to further consolidate its base in India in the medical devices manufacturing sector. As part of this, the company has decided to invest Rs. 1,200 crore to scale up and expand its current R&D centre into a state-of-the-art engineering
Industrial talks | 17/08/2020 | By Darshana | 507
Amazon India unveils e:pharmacy platform in Bengaluru, pilots likely in other cities
The Amazon Pharmacy service has currently opened in Bengaluru. The company plans its foray into other metros thereafter. Customers can now order via its platform: amazon.in all medicines via prescription. In addition nutraceuticals supplements, Ayurveda medicines and medical devices can also be ordered
Industrial talks | 14/08/2020 | By Darshana | 440
Sanofi Canada announced that Health Canada has approved Sarclisa in combination with pomalidomide and dexamethasone for the treatment of adults with relapsed and refractory multiple myeloma (RRMM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor
Industrial talks | 10/07/2020 | By Darshana | 489
India announces collaboration with Australia for Covid-19
Prime Minister Narendra Modi and the Prime Minister of Australia, Scott Morrison MP, announced a COVID-19 collaboration in 2020 during an India-Australia leaders' virtual summit held on June 4, 2020
Industrial talks | 08/06/2020 | By Darshana | 601
NPPA issues list of revised MRPs to ensure compliance on price of N- 95 mask
To ensure the availability of N-95 masks at the revised MRPs as per price control compliance, the National Pharmaceutical Pricing Authority (NPPA) has issued a list of price reduction in N-95 masks by four major N-95 mask manufacturers, namely Venus Safety and Health Pvt Ltd, Magnum Health and Safety, Yash Care Life Sciences and Joseph Leslie & Co
Industrial talks | 08/06/2020 | By Darshana | 537
Glenmark Pharma to study potential Covid-19 drug combination
Glenmark Pharmaceuticals Ltd said on Tuesday it would begin a clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, as a potential COVID-19 treatment
Industrial talks | 26/05/2020 | By Darshana | 464
Bayer has submitted an application for marketing authorization for its precision oncology treatment larotrectinib to the Ministry of Health, Labor and Welfare (MHLW) in Japan. Larotrectinib is an oral TRK inhibitor that has been developed specifically to treat adults and children
Industrial talks | 25/05/2020 | By Darshana | 607
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy